|
End-of-day quote
Korea S.E.
2026-10-28
|
5-day change | 1st Jan Change | ||
| 16,300.00 KRW | +2.00% |
|
-3.89% | -71.60% |
| 07-23 | Samsung EpiS Unit Signs Cancer Drug Development, Commercialization Deal with IntoCell | MT |
| 12-21 | IntoCell, Inc.(KOSDAQ:A287840) added to S&P Global BMI Index | CI |
Chart calendar IntoCell, Inc.
Upcoming events on IntoCell, Inc.
No events available
Past events on IntoCell, Inc.
| 2026-08-18 | Information meeting | 22:30 |
| 2026-03-25 | Annual General Meeting | 22:00 |
| 2025-12-19 | Présentation aux Actionnaires / Analystes | 00:00 |
Annual results
| Fiscal Period | December | 2024 |
|---|---|---|
|
Net sales | Released Forecast Spread | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 |
|
EBIT | Released Forecast Spread | 0,00 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 |
|
Net income Billions KRW | Released Forecast Spread | -9,91 |
|
EPS KRW | Released Forecast Spread | -756 |
| Announcement Date | 27/03/25 |
| 2026-10-28 | Board of Directors Meeting | ||
| 2026-10-28 | Board of Directors Meeting | ||
| 2026-10-28 | Earnings presentation | 22:00 | |
| 2026-10-29 | Earnings presentation | 08:30 | |
| 2026-10-29 | Earnings release - Q3 2026 | ||
| 2026-10-29 | Earnings release - Q3 2026 | ||
| 2026-10-29 | Earnings release - Q3 2026 | ||
| 2026-10-29 | Earnings release - Q3 2026 | ||
| 2026-10-29 | Earnings release - Q3 2026 | ||
| 2026-10-29 | Earnings presentation | 08:00 |
Past sector events for IntoCell, Inc.
| Today | Earnings presentation | 08:00 | |
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings presentation | 08:00 | |
| Today | Earnings release - Q2 2027 | ||
| Today | Analyst/Investor Day | 09:00 | |
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| 2026-10-27 | Earnings release - Q3 2026 | ||
| 2026-10-27 | Earnings presentation | 09:00 | |
| 2026-10-27 | Earnings release - Q3 2026 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A287840 Stock
- Calendar IntoCell, Inc.
Select your edition
All financial news and data tailored to specific country editions
















